- Telehealth Visits
- Insurance plan information
Tamar Meidav, MD
Child and Adolescent Psychiatry- Telehealth Visits
- Insurance plan information
Tamar Meidav, MD
Child and Adolescent Psychiatry- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Child & Adolescent Psychiatry, American Board of Internal Medicine
- Psychiatry, American Board of Internal Medicine
Fellowship
- Child and Adolescent Psychiatry, UCSF Graduate Medical Education
- Child and Adolescent Psychiatry, Cambridge Hospital
Residency
- Psychiatry, Cambridge Hospital
Internship
- Internal Medicine, Mount Sinai Medical Center - Cleveland - CLOSED
Degree
- MD, Case Western Reserve University School of Medicine
My expertise
Specialties
- Child and Adolescent Psychiatry
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%22648%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22648%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.